Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure supports binding to specific enzyme targets, making it valuable in drug discovery for neurological disorders and cancer therapies. The compound's fluorinated moiety enhances metabolic stability and bioavailability, which is advantageous in optimizing lead compounds during medicinal chemistry campaigns.